Citation Impact
Citing Papers
Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin
2009
Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro
2003 StandoutNobel
Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis
2009
Human Papillomaviruses and the Interferon Response
2009
Human Mismatch Repair
2005 StandoutNobel
Mechanisms in Eukaryotic Mismatch Repair
2006 StandoutNobel
Heparin-Protein Interactions
2002 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers
2002
Transduction of the E6 and E7 Genes of Epidermodysplasia-Verruciformis-Associated Human Papillomaviruses Alters Human Keratinocyte Growth and Differentiation in Organotypic Cultures
2001
Expression of Human Papilloma Virus E7 Protein Causes Apoptosis and Inhibits DNA Synthesis in Primary Hepatocytes via Increased Expression of p21Cip-1/WAF1/MDA6
2000
Determinants of Nuclear and Cytoplasmic Ubiquitin-mediated Degradation of MyoD
2003 StandoutNobel
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Ubiquitin-Proteasome-mediated Degradation of Id1 Is Modulated by MyoD
2004 StandoutNobel
PCNA binding proteins
1999
Cellular senescence: when bad things happen to good cells
2007 Standout
Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein
2000
Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit
2006 StandoutNobel
Expression of the HPV E7 Oncoprotein Mimics but Does Not Evoke a p53-Dependent Cellular DNA Damage Response Pathway
1999
Classification of papillomaviruses
2004 StandoutNobel
Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins
2007
Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
1999 StandoutNobel
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Head and neck cancer
2008 Standout
Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins
2009
Viruses in human cancers
1999 StandoutNobel
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
2002 Standout
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
1997
The Epigenomics of Cancer
2007 Standout
Oncogenic activities of human papillomaviruses
2009
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue
2000 StandoutNobel
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
2002 StandoutNature
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
2005 StandoutNobel
Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation
2002
Cancer genes and the pathways they control
2004 Standout
The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic Differentiation
2001
Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene
2001
The human papillomavirus E7 oncoprotein
2008
Viruses in human cancers
1999 StandoutNobel
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Destabilization of the RB Tumor Suppressor Protein and Stabilization of p53 Contribute to HPV Type 16 E7-Induced Apoptosis
1997
Overcoming inhibitions: subversion of CKI function by viral cyclins
1999
Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner
2002
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300
1999
A Comparative Analysis of the Interactions of the E6 Proteins from Cutaneous and Genital Papillomaviruses with p53 and E6AP in Correlation to Their Transforming Potential
1997
Human papillomavirus and cervical cancer
2007 Standout
The Cytokines Tumor Necrosis Factor-α (TNF-α) and TNF-related Apoptosis-inducing Ligand Differentially Modulate Proliferation and Apoptotic Pathways in Human Keratinocytes Expressing the Human Papillomavirus-16 E7 Oncoprotein
2001
p21WAF1/Cip1: more than a break to the cell cycle?
2000
Human papillomavirus immortalization and transformation functions
2002
Live or let die: the cell's response to p53
2002 Standout
Mechanism of Stimulation of Human DNA Ligase I by the Rad9-Rad1-Hus1 Checkpoint Complex
2006 StandoutNobel
Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21CIP-dependent pathways
2000
DNA replication and damage checkpoints and meiotic cell cycle controls in the fission and budding yeasts
2000 StandoutNobel
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
2001
The role of human papillomavirus oncoproteins E6 and E7 in apoptosis
2002
CDK Inhibitors: Cell Cycle Regulators and Beyond
2008
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
2008
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
The HPV E7 oncoprotein inhibits tumor necrosis factor α-mediated apoptosis in normal human fibroblasts
2001
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression
2001 StandoutNobel
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
A Defined Human System That Supports Bidirectional Mismatch-Provoked Excision
2004 StandoutNobel
Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins
2003
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
1999
A Novel Human DnaJ Protein, hTid-1, a Homolog of the Drosophila Tumor Suppressor Protein Tid56, Can Interact with the Human Papillomavirus Type 16 E7 Oncoprotein
1998
Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock
2004
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
2002 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology
2009
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Mechanisms of Human Papillomavirus-Induced Oncogenesis
2004
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus
2007
Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Centrosomal Component γ-Tubulin
2007
Purification and characterization of human DNA damage checkpoint Rad complexes
2001 StandoutNobel
Disruption of the G 1 /S Transition in Human Papillomavirus Type 16 E7-Expressing Human Cells Is Associated with Altered Regulation of Cyclin E
1998
Molecular biology of human papillomavirus infection and cervical cancer
2006
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation
1998
The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
2002
Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis.
2001
Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways
2000
Human Papillomavirus Type 16 E7 Maintains Elevated Levels of the cdc25A Tyrosine Phosphatase during Deregulation of Cell Cycle Arrest
2002
Human Papillomavirus Type 16 E7 Oncoprotein Can Induce Abnormal Centrosome Duplication through a Mechanism Independent of Inactivation of Retinoblastoma Protein Family Members
2003
Akt-Dependent Phosphorylation of p21Cip1 Regulates PCNA Binding and Proliferation of Endothelial Cells
2001
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals
1999
Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins
2002
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
THE DNA REPLICATION FORK IN EUKARYOTIC CELLS
1998
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Induction of p21WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16INK4a
1999
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Papillomavirus E6 and E7 proteins and their cellular targets
2007
Control of interferon signaling in human papillomavirus infection
2001
Cancer Genome Landscapes
2013 StandoutScience
Hepatitis C Virus IRES RNA-Induced Changes in the Conformation of the 40 S Ribosomal Subunit
2001 StandoutScienceNobel
Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins
2004
HPV-16 E7 Reveals a Link between DNA Replication Stress, Fanconi Anemia D2 Protein, and Alternative Lengthening of Telomere–Associated Promyelocytic Leukemia Bodies
2008
Cyclin-Dependent Kinase Inhibitor p21 Modulates the DNA Primer-Template Recognition Complex
1998
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint
1998
Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6
2008
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination
2001 StandoutNobel
Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
2003
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300
1999
Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV‐16 E7 oncoprotein
2001
Works of Erik Espling being referenced
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
1997
CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells
2009
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation
1996